Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ritonavir 80 mg/mL Solution, oral Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America and Abbott Laboratories (UK) Limited, Queensborough, Kent, England Norvir Ritonavir 100 mg Capsule Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America and Abbott Laboratories (UK) Limited, Queensborough, Kent, England Norvir Note: This consent is valid for 2 years from 30 Janaury 1999. Dated this 11th day of February 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.